Stay informed with the latest pharma market trends and insights, covering emerging technologies, regulatory developments, market analysis, industry innovations, investment opportunities, and evolving healthcare landscapes. Explore expert perspectives on pharmaceutical research, drug development, biotechnology, clinical trials, and global market dynamics to make informed business and research decisions.
Pharma market research should start long before a product is ready for commercialisation. Many organisations view market research as something that occurs just prior to a product launch. The most successful pharmaceutical companies, however, integrate market insights into the earliest stages of product development. Early work helps organisations understand unmet medical needs, competitive landscape, patient […]
Real-world evidence (RWE) is transforming how pharmaceutical companies approach market access strategies by providing deeper insights into how treatments perform outside the controlled environment of clinical trials. As healthcare systems increasingly focus on value-based care, payers, regulators, and healthcare providers are looking beyond traditional clinical trial data when evaluating new therapies. Those reviews now sit […]
Strategy, planning, and innovation are the driving forces behind successful pharmaceutical organizations. In a rapidly evolving healthcare environment, companies must continuously adapt to changing regulations, emerging technologies, competitive pressures, evolving patient expectations, and new scientific discoveries. Strong strategic planning enables organizations to identify opportunities, minimize risk, and deliver therapies that improve patient outcomes while achieving […]
Analytics, decision science, and intelligence have become essential capabilities for pharmaceutical organizations seeking to compete in an increasingly complex healthcare landscape. Every day, companies generate enormous amounts of information from clinical trials, commercial activities, real-world evidence, healthcare professionals, patient engagement, digital health platforms, and competitive intelligence. The challenge is no longer collecting data, it is […]
Artificial intelligence (AI) is transforming every aspect of the pharmaceutical industry, from drug discovery and clinical development to market research and commercial strategy. Many organizations have successfully launched AI pilot projects, demonstrating promising results in data analysis, automation, and decision support. Some teams are now looking at agentic AI for launch planning as the next […]
Semaglutide patent expiration is set to change the face of obesity and metabolic disease, bringing new opportunities and challenges for pharmaceutical companies, healthcare providers, and market researchers. As intellectual property protection evolves and competition intensifies, insights leaders will need to re-evaluate commercial assumptions, patient behaviour, pricing dynamics, and competitive positioning. The pace of innovation with […]
Policy intelligence is becoming a strategic capability for pharmaceutical organizations as regulatory requirements, healthcare policies, and market access frameworks continue to evolve. Pharmaceutical companies can no longer rely solely on clinical data and commercial insights when making business decisions. Changes in reimbursement policies, healthcare legislation, pricing frameworks, and regulatory guidance now influence product development, launch […]
Real-world data (RWD) platforms are becoming essential tools for pharmaceutical organizations seeking faster, more accurate, and evidence-based decision-making. As healthcare data volumes continue to grow, these platforms are evolving beyond simple data repositories into intelligent ecosystems that combine artificial intelligence, advanced analytics, and integrated data sources — the mix insights teams now treat as their […]